Cargando…

Therapeutic Potential of Microbiota Modulation in Alzheimer’s Disease: A Review of Preclinical Studies

Alzheimer’s disease (AD) is the most common neurodegenerative disease, yet it currently lacks effective treatment due to its complex etiology. The pathological changes in AD have been linked to the neurotoxic immune responses following aggregation of Aβ and phosphorylated tau. The gut microbiota (GM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benichou Haziot, Carla, Birak, Kulbir Singh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200201/ https://www.ncbi.nlm.nih.gov/pubmed/37220623 http://dx.doi.org/10.3233/ADR-220097

Ejemplares similares

Inhibitory Motor Control in Old Age: Evidence for De-Automatization?
por: Maylor, Elizabeth Ann, et al.
Publicado: (2011)

Age-related deficits in efficiency of low-level lateral inhibition
por: Schlaghecken, Friederike, et al.
Publicado: (2012)

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
por: Carranza-Naval, Maria Jose, et al.
Publicado: (2021)

The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study
por: López-Cuenca, Inés, et al.
Publicado: (2021)

Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
por: Tropea, Thomas F., et al.
Publicado: (2021)

Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences
por: de Andrade Teles, Roxana Braga, et al.
Publicado: (2018)

Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence
por: Khezri, Mohammad Rafi, et al.
Publicado: (2023)

Preclinical Studies of Posttraumatic Headache and the Potential Therapeutics
por: Tanaka, Mikiei, et al.
Publicado: (2022)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
por: Toniolo, Sofia, et al.
Publicado: (2020)

The Therapeutic Potential of Wogonin Observed in Preclinical Studies
por: Sharifi-Rad, Javad, et al.
Publicado: (2021)

Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease
por: Balendra, Vyshnavy, et al.
Publicado: (2021)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
por: Zhang, Xiao-Wen, et al.
Publicado: (2020)

Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
por: Singh, Anurag Kumar, et al.
Publicado: (2021)

Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review)
por: Yu, Yunhong, et al.
Publicado: (2021)

Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
por: Alshehri, Dikhnah, et al.
Publicado: (2021)

Therapeutic potential of resveratrol in Alzheimer's disease
por: Vingtdeux, Valérie, et al.
Publicado: (2008)

Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2018)

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
por: Andrade, Stephanie, et al.
Publicado: (2019)

Ferulic Acid in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
por: Wang, Er-Jin, et al.
Publicado: (2021)

Therapeutic Potential of Chungsangboha-tang for the Treatment of Asthma: A Review of Preclinical and Clinical Studies
por: Kang, Sung-Woo, et al.
Publicado: (2022)

Study partners should be required in preclinical Alzheimer’s disease trials
por: Grill, Joshua D., et al.
Publicado: (2017)

Clinical and Preclinical Studies of Fermented Foods and Their Effects on Alzheimer’s Disease
por: Kumar, Muganti Rajah, et al.
Publicado: (2022)

Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
por: Tokgöz, Sevilay, et al.
Publicado: (2021)

A Review of Oxylipins in Alzheimer’s Disease and Related Dementias (ADRD): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation
por: Shinto, Lynne H., et al.
Publicado: (2022)

Preclinical diagnosis of Alzheimer’s disease: Prevention or prediction?
por: Nitrini, Ricardo
Publicado: (2010)

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
por: Olasehinde, Tosin A., et al.
Publicado: (2017)

Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics
por: Yoo, Ki-Yeol, et al.
Publicado: (2012)

Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications
por: Akobeng, Anthony K., et al.
Publicado: (2020)

Modulation of L-type calcium channels in Alzheimer’s disease: A potential therapeutic target
por: Crossley, Chelsea A., et al.
Publicado: (2022)

The Potential Utility of Prebiotics to Modulate Alzheimer’s Disease: A Review of the Evidence
por: Kang, Jea Woo, et al.
Publicado: (2021)

Adipose tissue‐derived stem cells as a potential candidate in treatment of Alzheimer's disease: A systematic review on preclinical studies
por: Madani Neishaboori, Arian, et al.
Publicado: (2022)

Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease
por: Philips, Cyriac Abby, et al.
Publicado: (2019)

Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer's Disease
por: Minocha, Tarun, et al.
Publicado: (2022)

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Mulak, Agata
Publicado: (2021)

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
por: Hirschfeld, Lauren Rose, et al.
Publicado: (2022)

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
por: Varesi, Angelica, et al.
Publicado: (2022)

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
por: Rentz, Dorene M, et al.
Publicado: (2013)

Therapeutic Potential of Exosomes in Tendon and Tendon–Bone Healing: A Systematic Review of Preclinical Studies
por: Zou, Mingrui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9t5nm52sliuu36me64po9vh5nb